patient | Page 72 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

patient

Retired MDS Patient Living Life to the Fullest Since Transplant

Person's Name: 
Kathryn Bauer

I retired from Dun & Bradstreet, after 35 years of working all over the US and Europe as a business analyst and Vice President of Operations and Data Acquisition.  I was living the life I had always aspired to -- traveling, volunteering for a number of non-profit organizations, taking the occasional consulting job, enjoying a few classes at the local college, and just having fun.

Bone Marrow Disease(s): 
Content source: 

Timothy Graubert, MD

Graubert, Timothy
Director, Hematologic Malignancies Program, Hagler Family Chair in Oncology, Professor of Medicine
Massachusetts General Hospital, Harvard Medical School

Dr. Graubert’s research focuses on the molecular pathogenesis of myeloid leukemias. While at Washington University in St. Louis, he and his colleagues used genome sequencing technology extensively to gain insights into the genetic basis of human cancer and to use this information to improve risk stratification tools and identify targets for novel therapy.  Their group published the first complete genome sequence of a human cancer (

Mikkael Sekeres, MD, MS

Nimer, Stephen
Physician Liaison in Hematology and Chief of the Division of Hematology in the Department of Medicine
Sylvester Comprehensive Cancer Center and University of Miami

Mikkael A. Sekeres, MD, MS has been Medical Advisory Board Co-Chair since 2004. He is currently the Physician Liaison in Hematology and Chief of the Division of Hematology at the Sylvester Comprehensive Center at the University. Previously, Dr. Sekeres was the professor of medicine, director of the leukemia program, and Vice Chair for